Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...

In conclusion, COPD is a global disease, with increasing prevalence and health-related impact. The loss of FEV 1 may be slowing down, but what is really needed is an intervention that improves it in ...

Among older adults with established ASCVD, hospitalization for COPD increases risk of ASCVD hospitalization. The risk for atherosclerotic cardiovascular disease (ASCVD) hospitalization after chronic ...

Bronchiectasis is one of the most common highly heterogeneous chronic inflammatory airway diseases in China. It has a long course, heavy symptom burden, and is prone to recurrent acute exacerbations, ...